Clinical and educational impact of pharmacogenomics testing

A case series from the INGENIOUS trial

Rebecca C. Pierson, Brandon T. Gufford, Zeruesenay Desta, Michael Eadon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pharmacogenomic testing has become increasingly widespread. However, there remains a need to bridge the gap between test results and providers lacking the expertise required to interpret these results. The Indiana Genomics Implementation trial is underway at our institution to examine total healthcare cost and patient outcomes after genotyping in a safety-net healthcare system. As part of the study, trial investigators and clinical pharmacology fellows interpret genotype results, review patient histories and medication lists and evaluate potential drug-drug interactions. We present a case series of patients in whom pharmacogenomic consultations aided providers in appropriately applying pharmacogenomic results within the clinical context. Formal consultations not only provide valuable patient care information but educational opportunities for the fellows to cement pharmacogenomic concepts.

Original languageEnglish (US)
Pages (from-to)835-841
Number of pages7
JournalPharmacogenomics
Volume18
Issue number9
DOIs
StatePublished - Jun 1 2017

Fingerprint

Pharmacogenetics
Referral and Consultation
Clinical Pharmacology
Genomics
Drug Interactions
Health Care Costs
Patient Care
Genotype
Research Personnel
Delivery of Health Care
Safety
Pharmaceutical Preparations
Pharmacogenomic Testing

Keywords

  • clinical
  • education
  • genetic testing
  • pharmacogenetics
  • pharmacology
  • precision medicine

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Clinical and educational impact of pharmacogenomics testing : A case series from the INGENIOUS trial. / Pierson, Rebecca C.; Gufford, Brandon T.; Desta, Zeruesenay; Eadon, Michael.

In: Pharmacogenomics, Vol. 18, No. 9, 01.06.2017, p. 835-841.

Research output: Contribution to journalArticle

@article{2e52d1b9ddf14915866624a28eede068,
title = "Clinical and educational impact of pharmacogenomics testing: A case series from the INGENIOUS trial",
abstract = "Pharmacogenomic testing has become increasingly widespread. However, there remains a need to bridge the gap between test results and providers lacking the expertise required to interpret these results. The Indiana Genomics Implementation trial is underway at our institution to examine total healthcare cost and patient outcomes after genotyping in a safety-net healthcare system. As part of the study, trial investigators and clinical pharmacology fellows interpret genotype results, review patient histories and medication lists and evaluate potential drug-drug interactions. We present a case series of patients in whom pharmacogenomic consultations aided providers in appropriately applying pharmacogenomic results within the clinical context. Formal consultations not only provide valuable patient care information but educational opportunities for the fellows to cement pharmacogenomic concepts.",
keywords = "clinical, education, genetic testing, pharmacogenetics, pharmacology, precision medicine",
author = "Pierson, {Rebecca C.} and Gufford, {Brandon T.} and Zeruesenay Desta and Michael Eadon",
year = "2017",
month = "6",
day = "1",
doi = "10.2217/pgs-2017-0042",
language = "English (US)",
volume = "18",
pages = "835--841",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Clinical and educational impact of pharmacogenomics testing

T2 - A case series from the INGENIOUS trial

AU - Pierson, Rebecca C.

AU - Gufford, Brandon T.

AU - Desta, Zeruesenay

AU - Eadon, Michael

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Pharmacogenomic testing has become increasingly widespread. However, there remains a need to bridge the gap between test results and providers lacking the expertise required to interpret these results. The Indiana Genomics Implementation trial is underway at our institution to examine total healthcare cost and patient outcomes after genotyping in a safety-net healthcare system. As part of the study, trial investigators and clinical pharmacology fellows interpret genotype results, review patient histories and medication lists and evaluate potential drug-drug interactions. We present a case series of patients in whom pharmacogenomic consultations aided providers in appropriately applying pharmacogenomic results within the clinical context. Formal consultations not only provide valuable patient care information but educational opportunities for the fellows to cement pharmacogenomic concepts.

AB - Pharmacogenomic testing has become increasingly widespread. However, there remains a need to bridge the gap between test results and providers lacking the expertise required to interpret these results. The Indiana Genomics Implementation trial is underway at our institution to examine total healthcare cost and patient outcomes after genotyping in a safety-net healthcare system. As part of the study, trial investigators and clinical pharmacology fellows interpret genotype results, review patient histories and medication lists and evaluate potential drug-drug interactions. We present a case series of patients in whom pharmacogenomic consultations aided providers in appropriately applying pharmacogenomic results within the clinical context. Formal consultations not only provide valuable patient care information but educational opportunities for the fellows to cement pharmacogenomic concepts.

KW - clinical

KW - education

KW - genetic testing

KW - pharmacogenetics

KW - pharmacology

KW - precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85024486396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024486396&partnerID=8YFLogxK

U2 - 10.2217/pgs-2017-0042

DO - 10.2217/pgs-2017-0042

M3 - Article

VL - 18

SP - 835

EP - 841

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 9

ER -